One of the greatest mistakes that a forensic pa- thologist can make with toxicology is opining the cause of death based solely on a drug concen-
Examination of toxicology reports revealed that 69 7 of victims had some drug (including alcohol) in their system at the time of death For illegal drugs the
The critical essence of immunochemical assay methods is the rarity of false negatives If the drug is there, it will be so indicated, but there can be and there
Basically, it is the belief that drug levels will change in the blood in the postmortem period due to movement of drugs into the blood
Alcohol report issued (2-3 weeks) 3 If requested, drug analysis performed Drug toxicology report issued (2-8 months) g gy p ( ) 4 Samples will be
False-positive reports on urine drug myself, “What will I do with the results?” practice in forensic toxicology, should be
False-positive drug test results have been reported for many psychiatric drugs: When test results are unclear, the presence of drugs in the urine can be
drug, not all drugs can be considered in the same way This means that a Drug-impaired driving is often under-reported and under-recognized
Nevertheless, much of this can be reviewed against ante-mortem the toxicology findings may not be reported for several weeks after the body itself has
![[PDF] Criminal Law Section: Toxicology and the Courts [PDF] Criminal Law Section: Toxicology and the Courts](https://pdfprof.com/EN_PDFV2/Docs/PDF_7/41169_76thspringconf_tox_science_law.pdf.jpg)
41169_76thspringconf_tox_science_law.pdf
Toxicolog
y and the Courts:
Understandin
g and Inter p retin g the gpg
Scientific Evidence
~
Jennifer WilsonJennifer
Wilson
Program Coordinator, Toxicology Unit
Forensic Sciences DivisionMichigan State PoliceMichigan State
Police
T oxicologyoxicology • Toxicology:the study of the adverse effects of chemicals on or g anisms. g •Primary Tenet "All substances are poisons; there is none that is not a poison.
The dose differentiates a poison from a remedy".
PlP arace l sus Fiil ild h d fhdi ii • F orens i c tox i co l ogy i nc l u d es t h e stu d y o f t h e di spos i t i on of drugs in the body and their effects on function. PP urpose To analyze biological samples (blood, urine, breath) for alcohol and drug content and tobreath) for alcohol and drug content , and to assist courts and medical examiners to establish their likel y effects on the sub j ect. yj MttM arque tt e
Grayling
Bridgeport
Sterling Hts
Lansing
Grand Rapids
Sterling
Hts
Northville
MSP Toxicology UnitMSP
Toxicology
Unit
Lansing Laboratory
Analysis of blood, urine and other biological samples for alcohol and drugs of abuse. Anal y sis of bevera g es for alcohol content. yg
Toxicology Supervisor:Mr. Geoffrey French
Toxicology Program Coordinator:Ms. Jennifer Wilson
Staff of 10 forensic scientists and 1 technician
> 16,000 alcohol and 5,000 drug analyses per year.
Si dLS
c i ence an d L aw
Scientific World
View
Scientific
World - View The data is what it is.
R.A. Ludwig
Legal World
- View Legal World View It depends on what the definition of "is" is.
W. Clinton
Drugs Analyzed by MSP Toxicology
•Alcohol •Amphetamines•GHB •Hallucinogens•Antidepressants •Benzodiazepines •
Barbiturates
•Inhalants •Muscle Relaxants •
Narcotic Analgesics
Barbiturates
•Cannabinoids •Carbon Monoxide
Narcotic
Analgesics
•Non-prescription drugs •Opiates hl •Cocaine & metabolites •K2 or Spice •Bat h sa l ts •Other prescription and street drugs
MSP Laboratory OperationsMSP
Laboratory
Operations
1.Samples collected in cases of OUIL/OUID, CSC,
ME requests, other felonies or suspicious circumstances.2.All samples analyzed for alcohol content. Alcohol report issued (2-3 weeks).3.If requested, drug analysis performed.Dru
g toxicolo gy re p ort issued (
2-8 months
) . ggyp ( )
4.Samples will be discarded no less than two years after
receipt of samples.receipt of samples.
Number of Alcohol Cases AnalyzedNumber
of
Alcohol
Cases
Analyzed
Alcohol Cases Per Year
160001700014000150001200013000
Per Se OWI law passed
1000011000
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Y ea r A lcohol Gas Chromatograph
Alcohol Gas Chromatograph:Alcohol
Gas
Chromatograph:
Autosampler
Alcohol Testing MethodsAlcohol
Testing
Methods
Gas Chromatography
MSP Toxicology Laboratory.
Used for blood, urine, biological and beverage samples. Procedure: blood heated, ethanol evaporates, air (headspace) sampled. Advantages: clean, only volatiles will be detected. Specific: discriminates ethanol from isopropanol, etc.
State of the art for forensic labs.
Anal y st Techni q ue yq It is standard lab practice for all analysts always to: • Check the tube labels a g ainst the case file to be sure the ri g ht sam p le ggp was used; also check dates, times, spelling of names, etc. • Label all glassware. • Double-check all numbers and labels when removing sample from one tube to another.• Rinse or change pipettors and tips between samples. • Handle onl y one sam p le at a time. yp • Record anything unusual about the sample or its handling.
Kim Doing Alcohol AnalysisKim
Doing
Alcohol
Analysis
Blood and Urine Alcohol Analysis
Procedures:• Each sample is analyzed twice, once each on two separate instruments• The results must agree within 0.01 •
The lower number is reported.The
lower number is reported. • The instruments are calibrated weekly and multiple controls are run with every batch of samplescontrols are run with every batch of samples .
The MSP alcohol
p ro g ram has been described as pg one of the strongest in the country.
Analytical Procedures: AlcoholAnalytical
Procedures:
Alcohol
What's the "error rate" of your method?
What's the variability of your result?
Nhhi iill" "
• N o suc h t hi ng, stat i st i ca ll y, as " error rate " . • The variability allowed between instruments is 0.01 • The standard deviation between duplicate samples
run on the same instrument is 0.002What's the limit of detection of your method?• .001.• The third digit is truncated (.009 reported as .00)
Uncertainty in Tox Measurements
Soon we will be required by ASCLD to report ourSoon we will be required by ASCLD to report our "uncertainty measurement" on our alcohol reports. •Will be a +/- value followin g the blood alcohol result. g •Takes into account all possible error in our method. •Is available for defense attorneys and prosecutors at this time upon request. •It is likely that it will eventually be reported on the alcohol report for every casereport for every case . •Already is being reported for drug cases as a +/- percentage .
Blood vs SerumBlood
vs Serum What is the difference between blood and serum?What is the difference between blood and serum? Whole Blood: As it is drawn from the body; contains cells, water, p roteins. Red, more viscous than water or serum. Serum:Cells, most proteins removed; water fraction of blood
Clear yellowish Most hospitals analyze serumClear
, yellowish . Most hospitals analyze serum . Serum has more water per volume than blood, so the alcohol content will be higher in serum. The amount by which it will be higher dd hh i( fhbldhihill)d epen d s on t h e h ematocr i t ( percentage o f t h e bl oo d w hi c h i s ce ll s ) .
MSP uses a conversion factor of 16%, or 0.116:
0.116
g /dL serum ~ 0.100 d/dL whole bloo d g R etro g rade Extra p olation gp
Definition:Cl l i f bl d l hll l li iC
a l cu l at i on o f a bl oo d a l co h o l l eve l at an ear li er t i me from that of a blood sample taken at a later time.
Information Required:Information
Required:
• Times when subject began and finished drinking •
What and how much subject drankWhat
and how much subject drank • Food eaten • Weight • Drinkin g ex p erience gp Resultsare given as a range of possible values and are often challenged by defense experts.
Blood Alcohol Challenges:Blood
Alcohol
Challenges:
Procedural
A nalyst and Instrumentation • What ' sthe " error rate " of your method? Whats the error rate of your method? •Too many (or not enough) entries in maintenance logs •Calibration and/or controls not used enough or correctly
I t t tti i d t
• I ns t rumen t se tti ngs i na d equa t e •Repeat analyses mean you make a lot of mistakes •Blood tube may have been contaminated •Stopper may have been dried out •Chain of custody inadequate: who knows what the
Post Office did to the kit en route?Post
Office
did to the kit en route? •How well is the analyst really trained?
Alcohol Challen
g es: Inter p retation gp
My client...
- drank all the alcohol right before leaving the bar - drank after the accident - took an hour to absorb one beer - only had one drinkonly had one drink - wasn't the driver SS o: - the lab report is wrong - the lab report doesn't matter - s/he was below 0.08 at the time of the stop.
Til UiD TiT
ox i co l ogy U n i t D rug T est i n g
Purpose:
To discuss the different types of drug tests
available , and the stren g ths and limitations ,g of each.
To determine how to interpret the
information each t yp e of test p rovides. yp p
What Difference Does
SlMk? a S amp l e M a k e ?
Blood: indicates what is currently in the system
- what the central nervous system is being exposed to. - indicates possible or probable impairmentindicates possible or probable impairment .
Urine:indicates prior exposure
- may or may not correlate with impairment - drugs can show up in urine after they have been cleared from the blood - no magic threshold for "recent" vs "residual" urine level.
Which Test Was Done?Which
Test Was Done?
Hospital Lab •
If from patient treatment regimen most likely immunoassay only • If from patient treatment regimen , most likely immunoassay only . •Results (blood or urine): "Cannabinoid Positive"
MSP Lab•
Immunoassay screen, GC/MS confirmation.
•Results:
Blood:THC and THC-COOH present or
THC-COOH only present
Ui THC
COOH l t
U r i ne: THC - COOH on l y presen t .
What Dru
g s Tested f or? gf •Dipsticks: panel only. •
Immunoassay: panel onlyImmunoassay:
panel only •GC/MS: Most drugs, depending on the procedure used.BUT WILL h l bl kf d ? BUT : WILL t h e l a b l oo k f or most d rugs ?
Private labs
: you get only what you pay for.
If did 't k f S th ll 't t ti ll l k f itIf
you did n 't as k f or S oma, th ey usua ll y won 't au t oma ti ca ll y l oo k f or it .
Crime labs:
MSP will generally look for anything the assay can detect.
Caveat: may take longerCaveat:
may take longer . D ru g Anal y sis gy
Samples are analyzed twice by two different techniques:Screening Test (Randox Immunoassay BiochipArray)Screening
Test (Randox
Immunoassay
Biochip
Array)
••Detects classes of drugs• Disting ishes negati e from pres mpti e positi e samples •
Disting
u ishes negati v e from pres u mpti v e positi v e samples Confirmatory Test (GC/MS)••Sensitive: detects very small amounts of drug in a sample •
Specific: distinguishes individual drugsSpecific:
distinguishes individual drugs •State of the art, standard for forensic laboratories.
Testin
g Basics g
3 Steps in Drug Testing:3
Steps in Drug
Testing:
•Sample preparation •Conducting the test•Analyzing the data
Solid Phase ExtractionSolid
Phase
Extraction
Solid-phase extraction: removal of drugs from sample matrix by binding to absorbent material in the extraction column. Rest of sample discarded.
GC/MSGC/MS
•GC/MS: versatile and specific. Many different applications (environmental, academic, forensic).•Different procedures exist per drug or type of drug: -THC GHB - GHB - Most street/Rx drugs - Benzodiazepines (Valium, Xanax, Ativan) - Opiates, cocaine metabolites, amphetaminesOpiates, cocaine metabolites, amphetamines •Confirmation of all the drugs in a sample can require 3 or 4 procedures de p endin g on the needs of the case. pg
Gas Chromatograph/Mass SpectrometryGas
Chromatograph/Mass
Spectrometry
Confirmatory Tests (GC/MS)Confirmatory
Tests (GC/MS)
••Sensitive: detects very small amounts of drug in a sample (< 1 ng/ml).•Specific: distinguishes individual drugs and their metabolites.
•State of the art, standard for forensic laboratories.•Procedure: - Drug extracted from the blood/urine sample - Extract injected into the GC/MS - The sample is bombarded with an electron beam which breaks the drug molecule into pieces. - Pieces = mass spectra, or molecular "fingerprint" unique to each drug. •Spectra compared to databases: NIST, reference books, in-house libraries.
Gas Chromatograph/Mass SpectrometerGas
Chromatograph/Mass
Spectrometer
GC/MS:A
utosam p le r p I denti f ication o f Dru g s ffg Identification of DrugsGC/MS generates a molecular " fingerprint " of a drug that GC/MS generates a molecular fingerprint of a drug that can be matched to a database of mass spectral data: 477
Mass spectrum
of THC-COOH (PFP derivative,SIM mode MSP 477
489
625
640
SIM mode , MSP protocol).
Molecular
" fingerprint " of THC COOH
Molecular
fingerprint of THC - COOH .
Nothing else looks like this!
I denti f ication o f Dru g s ffg
Identification of Drugs
GC/MS
g enerates a molecular "fin g er p rint" of a dru g that ggpg can be matched to a database of mass spectral data: 8282
182
303Mass spectrum
of cocaine.
Molecular
" fingerprint " of cocaine
Molecular
fingerprint of cocaine .
Nothing else looks like this!
I nter p retation: Dru g s pg
Misidentification of Drugs: You mistook Tylenol for THC!Drug identification is NOT subjective! Based on:1. Database match of mass spectral data.
2. Agreement between screening and confirmatory tests.3. Presence of metabolites.4. Training, experience and proficiency of analyst.
I nter p retation: Dru g s pg
Misidentification of Drugs2.
Agreement between screening and confirmatory tests. 2.
Agreement
between screening and confirmatory tests. If the two didn't agree, the sample would automatically be re-analyzed.
3. Presence of metabolites.
Metabolites arise only within the body after ingestion4. Training, experience and proficiency of analyst.
MSP l t t k 1
2ffltii tt
MSP ana ly s t s t a k e 1 - 2 y ears o f f orma l t ra i n i n g , cons t an t proficiency testing. Defense experts we know don't do mass spectral analysis.
Mass Spectrometers
Number of Drug Cases AnalyzedNumber
of Drug Cases
Analyzed
Toxicology Cases Per Year
55006000650040004500500055002500300035004000
Blood THC analysis instituted
in Dec 2001
Per Se OWI law passed
Oct 1, 2003
1500
20002500
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
in Dec . 2001
Year Dru g s Found b y MSP ( 2011
) gy() Drug %ofCases Drug %ofCases Drug % of Cases Drug % of Cases
THC56Clonazepam4
Alprazolam24Zolpidem2Hydrocodone16Cyclobenzaprine 2
Cocaine 10Methamphetamine 2
Morphine12Trazodone 2S
10 Fl ti 2 S oma 10 Fl uoxe ti ne 2
Diazepam8Butalbital1
Diphenhydramine 7Phenobarbital1Codeine
6
Venlafaxine
1
Codeine
6
Venlafaxine
1
Methadone 5Propoxyphene1
Amphetamine5Sertraline1Citalopram
4 MDMA < 1
Citalopram
4 MDMA 1
Oxycodone4Fentanyl<1
Tramadol3
Drug ConsumptionDrug
Consumption
Absorptioninto the blood stream.
Distributionto organs and tissues.
Metabolismto inactive compounds.
Eliminationfrom the body.
Drugs and ImpairmentDrugs
and
Impairment
CNS Depressants
CNS Stimulants
CNS
Depressants
CNS
Stimulants
alcoholcocainebdii ht i b enzo di azep i nesamp h e t am i nes barbiturates hallucinogens opiates narcotic analgesics
GHBcarisoprodolcarisoprodol
marihuana inhalants All depressants share some symptoms of intoxication, as do all stimulants.
AntidepressantsAntidepressants
Common Antidepressants:Fl ti (P )
Nf d (S )
Fl uoxe ti ne (P rozac ) N e f aza d one (S erzone )
Sertraline (Zoloft) Paroxetine (Paxil)
Imipramine (Tofranil) Quetiapine (Seroquel)Risperdone (Risperdal) Doxepin (Sinequan)Bupropion (Wellbutrin) Amitriptyline (Elavil)Trazodone (Desyrel)
Nortriptyline (Aventyl)
Trazodone
(Desyrel)
Nortriptyline
(Aventyl) Citalopram (Celexa) Venlafaxine (Effexor)P ibl Sid Eff tP oss ibl e Sid e Eff ec t s: dizziness, drowsiness, confusion, disorientation, ataxia
Other Prescription DrugsOther
Prescription
Drugs DrugPossible Side Effects Medical UsesOlanzapine (Zyprexa) dizziness drowsiness schizophrenia
Olanzapine
(Zyprexa) dizziness , drowsiness schizophrenia Valproic Acid (Depakote) nausea, sedation bipolar disorder Methylphenidate (Ritalin) agitation, hallucination ADD/ADHD Chlor p romazine (
Thorazine
) drowsiness , confusion anti p s y chotic p() , py Thioridazine (Mellaril)drowsiness, confusion antipsychotic
Clozapine (Clozaril)seizuresantipsychotic
Phentermine (Adipex)agitation, confusion obesityCarbamazepine (Tegretol) seizuresanticonvulsant Cyclobenzaprine (Flexeril) drowsiness, dizziness muscle relaxant Buspirone (Buspar)drowsiness, dizziness anxiety disorders lid (A bi ) di i hi Zo l p id em (A m bi en ) se d at i on, amnes i a h ypnot i c
Doxylamine (Unisom) sedation hypnotic
Non-Prescri
p tion Dru g s pg
Caffeine, nicotine:not usually reporte
d
DrugPossible EffectsUsesIbuprofen,
Acetaminophen liver toxicity, pediatric overdose pain, fever reliefDiphenhydramine sedationantihistamine
Pseudoephedrine dizziness, agitation, tremor decongestantGuaifenesin
CNS depression
cough suppressant
Guaifenesin
CNS depression cough suppressant
Dextromethorphan sedationcough suppressant
I li id f h i ifi t t f th l
• I n li qu id f orm, many h ave s i gn ifi can t amoun t s o f e th ano l . • Growing abuse by minors for amphetamine or sedative properties. • May potentiate CNS-depressant actions of other drugs.
CannabinoidsCannabinoids
Detectable in Blood:12 - 18 hoursDetectable in Urine: 1
2 days in infrequent
Detectable
in
Urine:
1 - 2 days in infrequent users, up to 30 days in chronic users
Cannabis sativa
• Most common drug seen in MSP Lab: 1/2 of all cases • Linked to impaired driving and long-term damage to
Cannabis
sativa memory and learning. • N o overdoses re p orted (y et ) due to cannabinoids alone , p(y), but a common factor in auto fatalities, especially in young people.
Retrograde?Retrograde?
DMTDatamaster
THC C COO
0040.060.080.1
rAC TH C - COO H 00.02 0 . 04
68 122 201 262 319
B minutes after the end of drinking
THC M b li
Al h l M b li
THC M eta b o li sm Al co h o l M eta b o li sm A Short Histor y o f Cannabinoid Testimon y yfy
2004: P vs Derror (Grand Traverse Co.), P vs. Kurtz (Jackson Co.)•
Derror:
Fatal/serious PI accident only THC
COOH present
•
Derror:
Fatal/serious
PI accident , only THC - COOH present . • Subject acknowledged smoking marihuana earlier in the day. • Charged with per seOWI causing death/injury. •
Defense: THC
COOH not Schedule I
•
Defense:
THC - COOH not
Schedule
I . 2006
• MI Supreme Court affirms THC-COOH is a Schedule I compoun d .
2010 P vs Feezel
(
Washtenaw Co.
) () • MI Supreme Court reverses itself, overturns Derror. • Declares THC-COOH not a Schedule I compound.
How Are Things Different Now?How
Are
Things
Different
Now?
Pre-Derror (pre-per se)•
THC COOH presented as evidence of ingestion of controlled substance • THC - COOH presented as evidence of ingestion of controlled substance . • Not disputed that THC-COOH means ingestion of THC. • Not required to show THC present at time of stop (no retrogrades). •
Testimony on impairment generally required
•
Testimony
on impairment generally required .
Post-Feezel
• Cannot prosecute under MCL 257.625(8) with any amount of THC-COOH (p. 26). • Need to show THC itself present in system at time of stop • If a lab report doesn't list THC or distinguish THC from THC-COOH, can it be used as evidence? • Must a lab report show THC itself to be admissible? If so....
Controlled Substances
Controlled Substances (State of Michigan)
Public Health Code 333.7211-333. 7215
Schedule I.
No medical uses, high abuse potential.
THC (marihuana)MDMA(Ecstasy)MDMA
(Ecstasy) Designer amphetamines: MDA, DMA, PMA, DMT, DET, etc. Hallucinogens: PCP, LSD, mescaline, peyote, psilocin HeroinHeroinGHBA nd others.
Controlled Substances
Controlled Substances (State of Michigan)
Public Health Code 333.7211-333. 7215
Schedule II.Approved medical uses, high abuse potential - morphine, hydrocodone, oxycodone, codeine - methadone, Marinol (medicinal THC) h i h h i h l h id ( i li ) -amp h etam i ne, met h amp h etam i ne, met h y l p h en id ate ( R i ta li n ) and others AND " Coca leaf extracts and any salt preparation of derivative thereofCoca leaf extracts and any salt , preparation of derivative thereof .. including cocaine, salts, stereoisomers..." (333.7214.a.iv)
Controlled SubstancesControlled
Substances
Schedule III.Schedule
III. •Approved medical uses, lesser abuse potential than II. • Most barbiturates, ketamine, preparations with defined t f d i hi dih d d i
Schedule IV.amoun
t s o f co d e i ne, morp hi ne or dih y d roco d e i ne •Approved medical uses, abuse potential less than II
• Most benzodiazepines (Valium, Xanax), phentermineSchedule V.•Approved medical uses, abuse potential less than IV.•
Some preparations of ephedrine codeine morphine dih drocodeine • Some preparations of ephedrine , codeine , morphine , dih y drocodeine . • OTC ephedrine excepted.
Controlled Substances
Prescri
p tion Dru g s: pg •
• If not scheduled, not a controlled substance.• Considered to have little to no abuse or dependency
potential, but patient must be monitored for harmful effects.• Examples: antidepressants, antipsychotics, muscle relaxants. .
What Does It Mean?What
Does It Mean?
Schedule I:
Any drugs listed on CS Schedule IM t THC E t (N t THC
COOH!)
M os t common: THC , E cs t asy (N o t THC -
COOH!)
Section 7214(iv)(a):Coca leaf extracts and related compounds: cocaine So:any amount of THC, Ecstasy, cocaine or other Schedule I drugs in any body fluid is per seevidence of OUID
Charging OWI?Charging
OWI?
Still OWI!
- Schedule II - V drugs are still Controlled Substances.
V li X M b t A bi t
- V a li um, X anax, M epro b ama t e, A m bi en, e t c: prosecutor can still charge OWI although they are not Schedule I. - Schedule II - V: impairment must be proven, not a given.
Charging OWI?Charging
OWI?
Not OWI (?):
- Prescription drugs that are NOT controlled substances (e.g. Prozac, Effexor) - Over-the-counter drugs (Robitussin)- Inhalants (Dust-Off) or solvents (paint thinner)
Not controlled substances can
' t be charged under
257.625(8).
Not controlled substances , can t be charged under
257.625(8).
Independent TestsIndependent
Tests A second laboratory got different results. Why?Possible reasons: - Performed a different type of test
Screening test vs GC/MS; type of GC/MS done
-Test had different specificity
Dididbidjbid?D
etects ac idi c an d b as i c d rugs or j ust b as i c d rugs ? -Instrumentation had different sensitivity
What type of instrument detector?What
type of instrument detector?
Independent TestsIndependent
Tests A second laboratory got different results. Why?Possible reasons: - Different analyst performing the test
Trained in the detection of that drug?
- Laboratory has different cutoffsLab 1: c toff 1 ng/mlLab 1: c u toff = 1 ng/ml
Lab 2: cutoff = 10 ng/ml
Sample = 5 ng/ml.Lab 1: positive result Lab 2: negative resultLab 1: positive result . Lab 2: negative result .
Independent TestsIndependent
Tests A second laboratory got different results. Why?Possible reasons: - Samples tested at different times
Some drugs degrade in storage (i.e. cocaine)
- Samples may have been drawn at different sites on the bodyPostmortem distrib tion: femoral s thoracic bloodPostmortem
distrib u tion: femoral v s thoracic blood . - Interassay variability
Yields not always the same assay to assayYields
not always the same assay to assay .
Court ActivitiesCourt
Activities
Major Areas of Court Testimony:Analytical Procedures:
Analyst assigned the case
Analytical
Procedures:
Analyst
assigned the case
Expert Testimony:Toxicologist (usually Ph.D.)
• Interpretation of results •
Impairment issuesImpairment
issues • Blood alcohol calculations (retrograde extrapolation) • Rebuttal of defense experts (breath and blood cases)
Court CaseloadCourt
Caseload
SubpoenasSubpoenas~ 500 per person per yearO1 fldO R 1 per every f our cases comp l ete d
OR 2 per day, every day
20 -
40 court a
pp earances/ y ear
Video Testimony
pp y
Greatly reduces time spent on the road by scientists.Still not widely used due to defense objections andStill
not widely used due to defense objections and desire of prosecution to have witness appear in person.
ToxicologyToxicologyToxicologyToxicology
All substances are poisons; there is none
All substances are poisons; there is none
that is not a poison. The dose that is not a poison. The dose differentiates a poison from a remedy. differentiates a poison from a remedy.
ParacelsusParacelsusParacelsusParacelsus